John Serio is a firm partner, chair of its food and drug law practice, and member of the IP property and life sciences groups. He focuses on IP related to biotechnology, pharmaceuticals, medical devices, chemistry, healthcare and analytic scientific equipment. His practice involves the drafting and prosecution of patents, right to use and patentability opinions, patent litigation, licensing of technology, and trademark issues. He has extensive experience in FDA regulatory issues. Serio has gained experience advising clients on IP issues and strategy related to the acquisition, collaboration and licensing of life science technologies.